Significance of PD-L1 expressing tumor cells in the combined positive score with triple negative breast cancer

被引：0
|
作者：
Evans, Tiffany [1 ]
Hund, Stephanie [1 ]
Krohn, Darlene [1 ]
Emancipator, Kenneth [2 ]
Juco, Jonathon [2 ]
Portier, Bryce [1 ]
Tabuena-Frolli, Siena [1 ]
Kulangara, Karina [1 ]
机构：
[1] Agilent, Carpinteria, CA USA
[2] Merck Sharp & Dohme Corp, Kenilworth, NJ USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS4-15
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Characterizing PD-L1 Expressing Immune Cells in Triple Negative Breast Cancer by Multiplex Immunofluorescence
    Sun, Xiangjie
    Parra, Edwin
    Jiang, Mei
    Solis, Luisa
    Sahin, Aysegul
    Wistuba, Ignacio
    Litton, Jennifer
    Yang, Fei
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 273 - 274
  • [2] Characterizing PD-L1 Expressing Immune Cells in Triple Negative Breast Cancer by Multiplex Immunofluorescence
    Sun, Xiangjie
    Parra, Edwin
    Jiang, Mei
    Solis, Luisa
    Sahin, Aysegul
    Wistuba, Ignacio
    Litton, Jennifer
    Yang, Fei
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 273 - 274
  • [3] PD-L1 testing in triple negative breast cancer
    Dobritoiu, F.
    Chefani, A.
    Billingham, K.
    Chenard, M.
    Vaziri, R.
    Lacroix-Triki, M.
    Waydelich, A.
    Erb, G.
    Toro, P.
    Wedden, S.
    D'Arrigo, C.
    VIRCHOWS ARCHIV, 2019, 475 : S17 - S18
  • [4] Prognostic significance of PD-L1 expression on cancer, stromal, or immune cells in triple-negative breast cancer
    Behrendt, Carolyn E.
    Schmolze, Daniel B.
    Lee, Peter P.
    Apple, Sophia
    LABORATORY INVESTIGATION, 2018, 98 : 50 - 50
  • [5] Prognostic significance of PD-L1 expression on cancer, stromal, or immune cells in triple-negative breast cancer
    Behrendt, Carolyn E.
    Schmolze, Daniel B.
    Lee, Peter P.
    Apple, Sophia
    MODERN PATHOLOGY, 2018, 31 : 50 - 50
  • [6] Clinicopathological significance of PD-L1 expression in patients with triple-negative breast cancer
    Basheska, N.
    Ognenoska-Jankovska, B.
    HISTOPATHOLOGY, 2022, 81 : 26 - 27
  • [7] PD-L1 expressing circulating tumor cells (CTCs) in patients with breast cancer
    Zavridou, Martha
    Strati, Areti
    Malamos, Nikos
    Georgoulias, Vasilis
    Lianidou, Evi S.
    CANCER RESEARCH, 2016, 76
  • [8] The prognostic value of PD-L1/PD-1 expression and PD-L1 gene copy number on/in tumor and immune cells in triple negative breast cancer
    Seitz, S.
    Brockhoff, G.
    Weber, F.
    Klinkhammer-Schalke, M.
    Zeman, F.
    Ugocsai, P.
    Ortmann, O.
    Wege, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 4 - 4
  • [9] PD-L1 Expression in Triple-Negative Breast Cancer
    Mittendorf, Elizabeth A.
    Philips, Anne V.
    Meric-Bernstam, Funda
    Qiao, Na
    Wu, Yun
    Harrington, Susan
    Su, Xiaoping
    Wang, Ying
    Gonzalez-Angulo, Ana M.
    Akcakanat, Argun
    Chawla, Akhil
    Curran, Michael
    Hwu, Patrick
    Sharma, Padmanee
    Litton, Jennifer K.
    Molldrem, Jeffrey J.
    Alatrash, Gheath
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (04) : 361 - 370
  • [10] PD-L1 status of triple negative breast cancer in Russia
    Frank, G.
    Kuznetsova, O.
    Zavalishina, L.
    Andreeva, Y.
    Moskvina, L.
    Karaseva, V.
    Tjulandin, S.
    VIRCHOWS ARCHIV, 2020, 477 : S232 - S232
12345